Intracellular mechanisms of specific β-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 2, 2008, Pages 240-249

  Bartholomeu, Jan B ^a   Vanzelli, Andréa S ^a   Rolim, Natale P L ^a   Ferreira, Julio C B ^a   Bechara, Luiz R G ^a   Tanaka, Leonardo Y ^a   Rosa, Kaleizu T ^a   Alves, Márcia M ^b   Medeiros, Alessandra ^a   Mattos, Katt C ^a   Coelho, Marcele A ^a   Irigoyen, Maria C ^a   Krieger, Eduardo M ^a   Krieger, Jose E ^a   Negrão, Carlos E ^a   Ramires, Paulo R ^a   Guatimosim, Silvia ^b   Brum, Patricia C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Calcium transients; Heart failure; Oxidative stress; Sympathetic nervous system; adrenergic receptor antagonists

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CARVEDILOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; METOPROLOL; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION; TACHYCARDIA;

MUS;

EID: 48849100160     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.05.011     Document Type: Article

References (49)

1. Domanski M.J., Krause-Steinrauf H., Massie B.M., Deedwania P., Follmann D., Kovar D., et al. A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS. J Card Fail 9 5 (2003 Oct) 354-363
2. Hjalmarson A. Prevention of sudden cardiac death with beta blockers. Clin Cardiol 22 Suppl 5 (1999 Oct) V11-V15
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 9169 (1999 Jun 12) 2001-2007
4. Eichhorn E.J., and Bristow M.R. The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Curr Control Trials Cardiovasc Med 2 1 (2001) 20-23
5. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P., Komajda M., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 9377 (2003 Jul 5) 7-13
6. Sanderson J.E., Chan S.K., Yip G., Yeung L.Y., Chan K.W., Raymond K., et al. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J Am Coll Cardiol 34 5 (1999 Nov 1) 1522-1528
7. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 6 (2005 Sep 20) e1-e82
8. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 11 (2005 Jun) 1115-1140
9. Patterson A.J., Zhu W., Chow A., Agrawal R., Kosek J., Xiao R.P., et al. Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit Care Med 32 4 (2004 Apr) 1041-1048
10. Ahmet I., Krawczyk M., Heller P., Moon C., Lakatta E.G., and Talan M.I. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 110 9 (2004 Aug 31) 1083-1090
11. Feuerstein G.Z., and Ruffolo Jr. R.R. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 17 Suppl B (1996 Apr) 24-29
12. Piacentino III V., Weber C.R., Chen X., Weisser-Thomas J., Margulies K.B., Bers D.M., et al. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 92 6 (2003 Apr 4) 651-658
13. Janse M.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 61 2 (2004 Feb 1) 208-217
14. Sun Y.L., Hu S.J., Wang L.H., Hu Y., and Zhou J.Y. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats. Chest 128 3 (2005 Sep) 1812-1821
15. Sun Y.L., Hu S.J., Wang L.H., Hu Y., and Zhou J.Y. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart. Clin Exp Pharmacol Physiol 32 7 (2005 Jul) 553-560
16. Brum P.C., Kosek J., Patterson A., Bernstein D., and Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283 5 (2002 Nov) H1838-H1845
17. Rolim N.P., Medeiros A., Rosa K.T., Mattos K.C., Irigoyen M.C., Krieger E.M., et al. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure. Physiol Genomics 29 3 (2007 May 11) 246-252
18. Medeiros A., Rolim N.P., Oliveira R.S., Rosa K.T., Mattos K.C., Casarini D.E., et al. Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol (2007 Nov 1)
19. Johns C., Gavras I., Handy D.E., Salomao A., and Gavras H. Models of experimental hypertension in mice. Hypertension 28 6 (1996) 1064-1069
20. Guatimosim S., Sobie E.A., dos Santos Cruz J., Martin L.A., and Lederer W.J. Molecular identification of a TTX-sensitive Ca(2+) current. Am J Physiol Cell Physiol 280 5 (2001 May) C1327-C1339
21. Kubalova Z., Terentyev D., Viatchenko-Karpinski S., Nishijima Y., Gyorke I., Terentyeva R., et al. Abnormal intrastore calcium signaling in chronic heart failure. Proc Natl Acad Sci U S A 102 39 (2005 Sep 27) 14104-14109
22. Shannon T.R., Pogwizd S.M., and Bers D.M. Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 93 7 (2003 Oct 3) 592-594
23. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86 2 (2000 Feb 4) 152-157
24. Heymes C., Bendall J.K., Ratajczak P., Cave A.C., Samuel J.L., Hasenfuss G., et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41 12 (2003 Jun 18) 2164-2171
25. von Harsdorf R., Li P.F., and Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99 22 (1999 Jun 8) 2934-2941
26. Cesselli D., Jakoniuk I., Barlucchi L., Beltrami A.P., Hintze T.H., Nadal-Ginard B., et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89 3 (2001 Aug 3) 279-286
27. Hiraku Y., Murata M., and Kawanishi S. Determination of intracellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay. Biochim Biophys Acta 1570 1 (2002 Feb 15) 47-52
28. Nourooz-Zadeh J., Tajaddini-Sarmadi J., and Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220 2 (1994 Aug 1) 403-409
29. Curtis B.M., and O'Keefe Jr. J.H. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 77 1 (2002 Jan) 45-54
30. Francis G.S., Cohn J.N., Johnson G., Rector T.S., Goldman S., and Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993 Jun) VI40-VI48
31. Tilley D.G., and Rockman H.A. Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment. Expert Rev Cardiovasc Ther 4 3 (2006 May) 417-432
32. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 11 4 (2005 Apr) 409-417
33. Wang W., Zhu W., Wang S., Yang D., Crow M.T., Xiao R.P., et al. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ Res 95 8 (2004 Oct 15) 798-806
34. Ponicke K., Heinroth-Hoffmann I., and Brodde O.E. Role of beta 1- and beta 2-adrenoceptors in hypertrophic and apoptotic effects of noradrenaline and adrenaline in adult rat ventricular cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 367 6 (2003 Jun) 592-599
35. Zhu W.Z., Wang S.Q., Chakir K., Yang D., Zhang T., Brown J.H., et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest 111 5 (2003 Mar) 617-625
36. Gupta R.C., Mishra S., Rastogi S., Imai M., Habib O., and Sabbah H.N. Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts. Am J Physiol Heart Circ Physiol 285 6 (2003 Dec) H2373-H2381
37. Flesch M., Ettelbruck S., Rosenkranz S., Maack C., Cremers B., Schluter K.D., et al. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes. Cardiovasc Res 49 2 (2001 Feb 1) 371-380
38. Bilchick K.C., Duncan J.G., Ravi R., Takimoto E., Champion H.C., Gao W.D., et al. Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function. Am J Physiol Heart Circ Physiol 292 1 (2007 Jan) H318-325
39. Biesiadecki B.J., Kobayashi T., Walker J.S., John Solaro R., and de Tombe P.P. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res 100 10 (2007 May 25) 1486-1493
40. Pena J.R., and Wolska B.M. Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts. Cardiovasc Res 61 4 (2004 Mar 1) 756-763
41. Takeishi Y., Chu G., Kirkpatrick D.M., Li Z., Wakasaki H., Kranias E.G., et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 102 1 (1998 Jul 1) 72-78
42. Itoh S., Ding B., Bains C.P., Wang N., Takeishi Y., Jalili T., et al. Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation. J Biol Chem 280 25 (2005 Jun 24) 24135-24142
43. He X., Liu Y., Sharma V., Dirksen R.T., Waugh R., Sheu S.S., et al. ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes. Am J Pathol 163 1 (2003 Jul) 243-251
44. Kametani R., Miura T., Harada N., Shibuya M., Wang R., Tan H., et al. Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria. Circ J 70 3 (2006 Mar) 321-326
45. Chesley A., Lundberg M.S., Asai T., Xiao R.P., Ohtani S., Lakatta E.G., et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87 12 (2000 Dec 8) 1172-1179
46. Communal C., Singh K., Sawyer D.B., and Colucci W.S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100 22 (1999 Nov 30) 2210-2212
47. Zaugg M., Xu W., Lucchinetti E., Shafiq S.A., Jamali N.Z., and Siddiqui M.A. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102 3 (2000 Jul 18) 344-350
48. Bernstein D., Fajardo G., Zhao M., Urashima T., Powers J., Berry G., et al. Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 289 6 (2005 Dec) H2441-2449
49. Tevaearai H.T., and Koch W.J. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts. Trends Cardiovasc Med 14 6 (2004 Aug) 252-256